Development and Qualification of an Antigen Integrity Assay for a <i>Plasmodium falciparum</i> Malaria Transmission Blocking Vaccine Candidate, Pfs230
During development of a subunit vaccine, monitoring integrity of the recombinant protein for process development and quality control is critical. Pfs230 is a leading malaria transmission blocking vaccine candidate and the first to reach a Phase 2 clinical trial. The Pfs230 protein is expressed on th...
Main Authors: | Kazutoyo Miura, Thao P. Pham, Shwu-Maan Lee, Jordan Plieskatt, Ababacar Diouf, Issaka Sagara, Camila H. Coelho, Patrick E. Duffy, Yimin Wu, Carole A. Long |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/10/1628 |
Similar Items
-
The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate
by: Shwu-Maan Lee, et al.
Published: (2019-11-01) -
Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose
by: Wei-Chiao Huang, et al.
Published: (2020-08-01) -
Development of a Cell-Based Reporter Potency Assay for Live Virus Vaccines
by: Dengyun Sun, et al.
Published: (2024-07-01) -
A Self-Assembling Pfs230D1-Ferritin Nanoparticle Vaccine Has Potent and Durable Malaria Transmission-Reducing Activity
by: Nichole D. Salinas, et al.
Published: (2024-05-01) -
Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine
by: Michael Theisen, et al.
Published: (2017-04-01)